Creator's personal experience with NMN, NMNH, NR and NAD⁺ risks
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedThe description presents the creator's personal experience and research on NMN, NMNH, NR and NAD⁺, including a cited EFSA opinion on beta-NMN safety and bioavailability. It states NMN is treated as an unapproved novel food and research chemical in the EU and contains affiliate links. [1]
The creator says personal use of NMN or NMNH, legally treated as research chemicals, is only a personal decision and not a recommendation. [1]
The description cites an EFSA opinion on beta-NMN safety and on nicotinamide bioavailability from this source. [1]
Links marked with an asterisk are affiliate partner links that earn the creator a small commission at no extra cost. [1]
Creator's stated personal experience with NMN and NMNH
According to the description, the creator shares personal experiences, thoughts, research and subjective impressions. It says the creator's use of substances such as NMN or NMNH, legally classified as research chemicals, reflects only a personal decision and is not a recommendation. The description also states that NMN counts in the European Union as an unapproved novel food and is legally classified as a research chemical not suitable for human consumption. [1]
Cited EFSA opinion on beta-NMN safety and bioavailability
The description lists an EFSA scientific opinion on beta-nicotinamide mononucleotide (β-NMN) as a study source. The cited title refers to the safety of β-NMN under Regulation (EU) 2015/2283 and to the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC. The description gives no results or conclusions from that opinion. [1]
Affiliate links and disclaimer in the creator's description
The description contains links marked as affiliate partner links; a purchase through them earns the creator a small commission at no extra cost to the buyer. It also includes a disclaimer stating the content is for neutral information and general education, is not a recommendation or advertising for the mentioned foods, supplements, methods or procedures, and does not replace advice from a doctor or pharmacist. [1]
Context & limits
Only the video description was available; the video and transcript were not reviewed. The description gives no study results, sample sizes or outcome data, and the cited EFSA opinion's findings are not summarized. Statements about personal experience are the creator's own account, not verified evidence.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
spiegelt ausschließlich meine persönliche und selbstverantwortliche Entscheidung
Safety of beta-nicotinamide mononucleotide (β-NMN)
erhalte ich eine kleine Provision – ohne
About this video
Creator description · original textText language: German
Elisabeth-Eberl · 8 min · Source published: 2026-10-21
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.